Clinical Trial

Standardization of IMT Dosage (UTIT) in Mechanical Ventilation.

Study acronym: UTIT-IMT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Respiratory muscle weakness prolongs mechanical ventilation (MV) and delays weaning. Currently, there is no standardized dosage for Inspiratory Muscle Training (IMT) in the ICU. This study aims to define an optimal IMT dosage using a new metric called "Total Inspiratory Work Unit" (UTIT), which integrates intensity, repetition, and frequency. The study compares three daily dosage regimens (1,000 UTIT, 2,000 UTIT, and 3,000 UTIT) adjusted daily based on the patient's Negative Inspiratory Force (NIF). The goal is to determine the optimal dose-response relationship for improving inspiratory muscle strength (PiMax) and reducing the duration of mechanical ventilation.
Trial Details
NCT Number NCT07761468
Lead Sponsor Hospital H+ Queretaro
Conditions Ventilator Induced Diaphragm Dysfunction, Respiratory Muscle Weakness, Mechanical Ventilation Weaning
Enrollment 60 participants
Start Date 2025-08-01
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-12